Rapafusyn Pharmaceuticals
About:
Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle.
Website: https://rapafusyn.com/
Top Investors: Lapam Capital, 3E Bioventures, Prox Ventures
Description:
Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle. The company develops novel pharmaceuticals to treat patients having diseases and fulfill other unmet medical needs.
Total Funding Amount:
$28M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Baltimore, Maryland, United States
Founded Date:
2015-01-01
Contact Email:
contact(AT)rapafusyn.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-06-20
IPO Status:
Private
Industries:
© 2025 bioDAO.ai